The information highlighted (if any) are the most recent updates for this brand.
Idarucizumab (Praxbind) is a specific reversal agent for dabigatran and is indicated in adult patients treated with dabigatran etexilate (Pradaxa) when rapid reversal of its anticoagulant effects is required: For emergency surgery/urgent procedures; In life-threatening or uncontrolled bleeding.